The specific N-methyl -d -aspartate (NMDA) receptor antagonist MK-801 blocks U-50,488, but not morphine antinociception
- 28 August 1992
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 589 (1), 139-142
- https://doi.org/10.1016/0006-8993(92)91173-c
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the ratBrain Research, 1992
- Delayed application of MK-801 attenuates development of morphine tolerance in ratsBrain Research, 1991
- Neuroprotective actions of GR89696, a highly potent and selective κ‐opioid receptor agonistBritish Journal of Pharmacology, 1991
- Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the ratBrain Research, 1991
- Action site of adrenergic blockers to suppress the development of tolerance to morphine analgesiaBrain Research, 1990
- N‐methyl‐D‐aspartate antagonists: Ready for clinical trial in brain ischemia?Annals of Neurology, 1989
- Effects of morphine in rats treated chronically with U-50,488 H, a κ opioid receptor agonistEuropean Journal of Pharmacology, 1989
- MK-801 is neuroprotective in gerbils when administered during the post-ischaemic periodNeuroscience, 1988
- Kappa opioid analgesicsDrugs of the Future, 1988
- Binding selectivity profiles for ligands of multiple receptor types: Focus on opioid receptorsTrends in Pharmacological Sciences, 1987